Myofibroblasts: The ideal target to prevent arteriovenous fistula failure?

15Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The arteriovenous fistula (AVF) failure is a major cause of morbidity in the hemodialysis population. Most AVFs fail due to neointimal hyperplasia (NIH). In this issue, Yang et al. delineated a mechanism responsible for transforming the fistula adventitia into a fertile soil for neointimal precursors. These authors pondered the role of hypoxia-regulated hypoxia-inducible factor-1 (HIF-1α), vascular endothelial growth factor A (VEGF-A), and matrix metalloproteinases (MMPs) in the activation of those adventitial myofibroblasts that may significantly contribute to the formation of the fistula neointima. © 2013 International Society of Nephrology.

Cite

CITATION STYLE

APA

Duque, J. C., & Vazquez-Padron, R. I. (2014). Myofibroblasts: The ideal target to prevent arteriovenous fistula failure? Kidney International. Nature Publishing Group. https://doi.org/10.1038/ki.2013.384

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free